Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Corticosteroid Studies Assessing Growth Effects Should Not Start Before Age 3

Executive Summary

FDA's final guidance on studying the effects of inhaled and intranasal corticosteroids on growth in children narrows the recommended lower age limit for patients to three years of age

You may also be interested in...

Inhaled Corticosteroid Growth Studies Need Rescue Medication Plan – FDA

Studies evaluating the effect of orally inhaled and intranasal corticosteroids on growth in children should include an action plan for how to treat worsening symptoms, an FDA draft guidance recommends

Rx Importation Legislation Debate Begins Anew, But Battle Lines Are Familiar

Sens. Byron Dorgan, D-S.D., and Olympia Snowe, R-Maine, are trying to build momentum for their proposal to allow prescription drug importation, vowing at a March 7 hearing that they will push to bring the measure quickly to the Senate floor

FDA Calls For Third-Party Auditor To Rectify Actavis Manufacturing Problems

FDA is recommending that Actavis "promptly initiate" a third-party audit program to oversee the correction of manufacturing discrepancies at the firm's Little Falls, N.J. facility, following the second warning letter for the plant in less than five months




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts